|
π
|
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.
23 auth.
A. Shaw,
B. Yeap,
B. Solomon,
Gregory Riely,
J. Gainor,
J. Engelman,
G. Shapiro,
D. Costa,
S. Ou,
M. Butaney,
...
R. Salgia,
R. Maki,
M. Varella-Garcia,
R. Doebele,
Y. Bang,
K. Kulig,
P. Selaru,
Yiyun Tang,
K. Wilner,
E. Kwak,
Jeffrey W. Clark,
A. Iafrate,
D. Camidge
|
9 |
2011 |
9
π
|
|
π
|
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH
14 auth.
E. Yi,
J. Boland,
J. Maleszewski,
A. Roden,
Andre M Oliveira,
M. Aubry,
M. Erickson-Johnson,
B. Caron,
Yan Li,
Hui Tang,
...
Shawn M. Stoddard,
J. Wampfler,
K. Kulig,
Ping Yang
|
8 |
2011 |
8
π
|
|
π
|
Nerve growth factor production by lymphocytes.
7 auth.
L. Santambrogio,
M. Benedetti,
M. Chao,
R. Muzaffar,
K. Kulig,
N. Gabellini,
...
G. Hochwald
|
7 |
1994 |
7
π
|
|
π
|
Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma
16 auth.
Ping Yang,
K. Kulig,
J. Boland,
M. Erickson-Johnson,
Andre M Oliveira,
J. Wampfler,
A. Jatoi,
C. Deschamps,
R. Marks,
C. Fortner,
...
Shawn M. Stoddard,
F. Nichols,
J. Molina,
M. Aubry,
Hui Tang,
E. Yi
|
7 |
2012 |
7
π
|
|
π
|
PDβL1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
26 auth.
Hui Yu,
C. Batenchuk,
A. Badzio,
T. Boyle,
P. Czapiewski,
D. Chan,
Xian Lu,
D. Gao,
K. Ellison,
Ashley A. Kowalewski,
C. Rivard,
R. Dziadziuszko,
Caicun Zhou,
M. Hussein,
D. Richards,
...
S. Wilks,
M. Monte,
W. Edenfield,
J. Goldschmidt,
R. Page,
B. Ulrich,
D. Waterhouse,
S. Close,
J. Jassem,
K. Kulig,
F. Hirsch
|
6 |
2017 |
6
π
|
|
π
|
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
9 auth.
H. Park,
J. Lee,
Dong-Wan Kim,
K. Kulig,
T. Kim,
Se-Hoon Lee,
...
Y. Jeon,
D. Chung,
D. Heo
|
6 |
2012 |
6
π
|
|
π¦
|
Sexual activity and substance use among adolescents by category of physical activity plus team sports participation.
K. Kulig,
N. Brener,
Tim Mcmanus
|
6 |
2003 |
6
π¦
|
|
π
|
Comparative analyses of overall survival in patients with anaplastic lymphoma kinaseβpositive and matched wildβtype advanced nonsmall cell lung cancer
11 auth.
J. Lee,
H. Park,
Dong-Wan Kim,
K. Kulig,
Tae Min Kim,
Se-Hoon Lee,
...
Y. Jeon,
D. Chung,
D. Heo,
W. Kim,
Y. Bang
|
5 |
2012 |
5
π
|
|
π¦
|
Physical and Functional Association of the Major Histocompatibility Complex Class I Heavy Chain Ξ±3 Domain with the Transporter Associated with Antigen Processing
K. Kulig,
D. Nandi,
I. BacΜiΜk,
J. Monaco,
S. VukmanoviΔ
|
5 |
1998 |
5
π¦
|
|
π
|
Impact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controls.
20 auth.
A. Shaw,
B. Yeap,
B. Solomon,
Gregory Riely,
A. Iafrate,
G. Shapiro,
D. Costa,
M. Butaney,
S. Ou,
R. Maki,
...
Y. Bang,
M. Varella-Garcia,
R. Salgia,
K. Wilner,
K. Kulig,
P. Selaru,
Y. Tang,
E. Kwak,
J. Clark,
D. Camidge
|
5 |
2011 |
5
π
|
|
π
|
Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images
19 auth.
Apaar Sadhwani,
Huan-Wei Chang,
A. Behrooz,
Trissia Brown,
Isabelle Auvigne-Flament,
Hardik Patel,
R. Findlater,
Vanessa Velez,
Fraser Tan,
Kamilla Tekiela,
...
Ellery Wulczyn,
E. Yi,
C. Mermel,
D. Hanks,
Po-Hsuan Cameron Chen,
K. Kulig,
C. Batenchuk,
David F. Steiner,
Peter Cimermancic
|
5 |
2021 |
5
π
|
